Inventor

HAKOMORI SEN-ITIROH

US51 patents

⚠️ This page may combine multiple inventors who share the name “HAKOMORI SEN-ITIROH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HAKOMORI SEN-ITIROH

BIOMEMBRANE INST

Effect of n,n,n-trimethylsphingosine on protein kinase-c activity, melanoma cell growth in vitro, metastatic potential in vivo and human platelet aggregation

Method for inhibition of cell motility by sphingosine-1-phosphate, its derivatives and mimetics and method of synthesizing sphingosine-1-phosphate and its derivatives

Effect of N,N,N-trimethylsphingosine on protein kinase-C activity; melanoma cell growth in vitro; metastatic potential in vivo and human platelet aggregation

Method for inhibiting selectin-dependent adhesion of leukocytes and platelets by O-glycosylation modification

Method for inhibition of cell motility by sphingosine-1-phosphate and derivatives

ABO genotyping

Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human and with synthetic carbohydrate-carrier conjugates

Effect of N,N,N,-trimethylsphingosine on protein kinase C activity melanoma cell growth in vitro; metastatic potential in vivo and human platelet aggregation

Carbohydrate ligands (myelorollin) that cause E-selectin dependent cell rolling and adhesion under dynamic flow system

Methylsphingosine used to treat apoptosis

Methods for the production of antibodies and induction of immune responses to tumor-associated gangliosides by immunization with ganglioside lactones

Method for the production of monoclonal antibodies directed to tumor-associated gangliosides and fucogangliosides

Extended type 1 chain glycosphingolipids as tumor-associated antigens

Synthesis of Lex ; dimeric Lex (difucosyl Y2 ; III3 FucV3 FucnLc6 Cer); sialylated forms thereof; and analogues thereof

Method of preparing N,N,N-trimethylsphingosine

Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugates

Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with carbohydrate-carrier conjugates

Purified histo-blood group a glycosyltransferase and antibodies thereto

Naturally occurring gangliosides containing de-N-acetyl-sialic acid and their applications as modifiers of cell physiology

Monoclonal antibody nuh2 capable of inactivating motility of human sperm, antigen defined by said monoclonal antibody and methods of using said monoclonal antibody and antigen

Methods for the production of antibodies and induction of immune responses to tumor-associated gangliosides by immunization with ganglioside lactones

Methods for the production of antibodies and induction of immune responses to tumor-associated ganagliosides by immunization with gangloiside lactones

Trifluoromethyl analogs of fucose and uses thereof

Extended type 1 chain glycosphingolipids as tumor-associated antigens

Blood treatment method

Long-chain glycolipid structure

Antibody-mediated and ligand-mediated targeting of differentiation-inducers to tumor cells

Antibodies that bind novel carbohydrate ligands (myelorollins) that cause E-selectin dependent cell rolling, and uses thereof

HUTCHINSON FRED CANCER RES

Monoclonal antibody defining oncofetal structure of fibronectin

Monoclonal antibody that specifically binds to disialosyl Lea

Hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside

Oncofetal structure of fibronectin

Onco-developmentally regulated α-N-acetylgalactosaminyltransferase

Disialofucoganglioside immunogen and fucoganglioside monosialosyl Lea II

Oncofetal fibronectin epitope

ONCOMEMBRANE INC

Sphingosine-1-phosphate/trimethylsphingosine composition

Method for quantifying sphingosine and for diagnosing platelet activation

Trimethylsphingosine derivatives

Plasmalopsychosines and plasmalocerebrosides

UNIV WASHINGTON

Method for determining susceptibility to Escherichia coli urinary tract infections, method for diagnosing secretors and nonsecretors, and method and medicament for preventing Escherichia coli urinary tract infections

Chlamydia oligosaccharides

Compositions for treating Escherichia coli urinary tract infections

Chlamydia oligosaccharides

CELL THERAPEUTICS INC

Growth stimulating factors

Growth stimulating factors

ONCOMEMBRANE

Sphingosine-1-phosphate essentially free of L-threo isomer

OTSUKA AMERICA PHARMACEUTICAL

Method for inhibition of cell motility by sphingosine-1-phosphate and its derivatives

SLOAN KETTERING INST CANCER

Monoclonal antibody panel for blood group a antigen

BIOMEMBRANE INTSTITUTE

Plasmalopsychosines and plasmalocerebrosides

CHANG TONG-HSUAN

Anti-extended type I glycosphingolipid antibody, derivatives thereof and use